Home » Topics » BioWorld Science

BioWorld Science
RSS

MedImmune presents novel bivalent bispecific antibody MEDI-1109

May 2, 2018

Starpharma completes rolling NDA submission for VivaGel BV

May 2, 2018

GlaxoSmithKline reflects on accomplishments of first quarter 2018

May 2, 2018

Crescendo Biologics completes Series B financing

May 2, 2018

Novel PD-1/GITRL bispecific fusion proteins demonstrate antitumor activity in vivo

May 2, 2018

Trogarzo becomes available in the U.S.

May 2, 2018

Rhopressa launched in the U.S. for lowering intraocular pressure

May 2, 2018

4DMT and Roche expand ophthalmology partnership

May 2, 2018

European approval recommended for Perjeta as post-surgery treatment of HER2-positive breast cancer

May 2, 2018

Accelerator Life Science Partners launches Proniras

April 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...